
|Videos|October 3, 2017
Leiomyosarcoma Patient Discusses Treatment Roadmap, Challenges
Author(s)Lauren Santye, Assistant Editor
Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.
Advertisement
Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Accepts Furosemide Autoinjector sNDA for Treatment of Edema in Chronic Kidney Disease or Chronic Heart Failure
2
FDA Approves Pirtobrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia
3
Pharmacists Can Advance Lung Cancer Screening Awareness in High-Risk Patients
4
A Closer Look at Interdisciplinary Care with Unit-Based Pharmacy
5



















































































































































































































